IASIC Speaker Series Presents  Cannabis and Mental Health

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed, organized, and guided by doctors.

Session: Cannabis and Mental Health
Presented By: Thida Thant
Date: Tuesday, January 17, 2023
Time: 1:00 PM Eastern/10:00 AM Pacific
Price: FREE
This session will review the literature regarding cannabis and its impact on various mental health disorders. It will discuss how to consider the current state of literature in the context of your patient’s clinical presentation, how to evaluate the risk/benefit in your patient and how to approach psychoeducation regarding the impact of cannabis on mental health disorders such as depression, bipolar, anxiety, sleep and psychosis.

Dr. Thida Thant is an assistant professor and consultation-liaison (CL) psychiatrist at the University of Colorado Department of Psychiatry. She graduated with a Bachelor of Arts Degree in Plan II honors from the University of Texas at Austin, attended medical school at the University of Texas Medical School in Houston and completed her general adult psychiatry residency and psychosomatic medicine fellowship at the University of Colorado. She is currently the director of the University of Colorado Consultation-Liaison Psychiatry Service and the Psychiatric Consultation for the Medically Complex clinic (PCMC) in the Department of Psychiatry at the University of Colorado Anschutz Medical Campus. Her academic interests include marijuana and its impact on psychiatric practice in states with legalized marijuana, the creation and implementation of marijuana curricula in medical education and psychiatric care for medically and neurologically complex patients. She has spoken at multiple conferences on the topics of chronic medical illness, marijuana and consultation-liaison psychiatry, has authored book chapters about cannabis in books such as Marijuana and Mental Health and Cannabis in Medicine and has developed and published a cannabis curriculum through AAMC’s MedEdPortal titled “What You Need to Know About Cannabis: An Evidence-Based Crash Course for Mental Health Trainees.”

Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest

Related Posts

IASIC Speaker Series Presents: Impacts of Maternal Cannabis Use on Long-Term Psychiatric Risk

The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,

Libby Stuyt Interview on Randy Tobler show

Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when

Medical marijuana access and prolonged opioid use among adolescents and young adults

Abstract Background and Objectives Laws liberalizing access to medical marijuana are associated with reduced opioid analgesic use among adults, but little is known about the impact of such policies on adolescents and young adults. Methods This retrospective cohort study used 2005 to 2014 claims from MarketScan® Commercial database, which covers all 50 states and Washington

Scroll to Top